Search

Your search keyword '"Fereday"' showing total 109 results

Search Constraints

Start Over You searched for: Author "Fereday" Remove constraint Author: "Fereday" Topic female Remove constraint Topic: female
109 results on '"Fereday"'

Search Results

1. Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer

2. Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

3. The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.

4. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

5. CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

6. Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

7. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery

8. Profiling the immune landscape in mucinous ovarian carcinoma.

9. High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival

10. Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

11. Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

12. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

13. Prognostic gene expression signature for high-grade serous ovarian cancer.

14. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

15. Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.

16. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium

17. Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer

18. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas

19. Profiling the immune landscape in mucinous ovarian carcinoma

20. The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer

21. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

22. TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

23. High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival

24. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

25. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision

26. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

27. Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

28. Germline BRCA variants, lifestyle and ovarian cancer survival

29. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

30. Therapeutic options for mucinous ovarian carcinoma☆

31. The molecular origin and taxonomy of mucinous ovarian carcinoma

32. Using provider–parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial protocol

33. Evolution of core archetypal phenotypes in progressive high grade serous ovarian cancer

34. Pan-cancer analysis of whole genomes

35. Sex differences in oncogenic mutational processes

36. Identification of a Locus Near

37. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium

38. Aboriginal and Torres Strait Islander women's experiences accessing standard hospital care for birth in South Australia – A phenomenological study

39. Cultural safety and midwifery care for Aboriginal women – A phenomenological study

40. Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer

41. Effectiveness of a programme comprising serial casting, botulinum toxin, splinting and motor training for contracture management: a randomized controlled trial

42. Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype

43. The role of time perception in temporal binding: Impaired temporal resolution in causal sequences

44. Extra practice outside therapy sessions to maximize training opportunity during inpatient rehabilitation after traumatic brain injury

45. Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance

46. Psychosocial Outcomes of a Randomized Controlled Trial of Outpatient Cervical Priming for Induction of Labor

47. An evaluation of the satisfaction of midwives’ working in midwifery group practice

48. Factors Influencing the Overall Satisfaction in Patients With Severe Brain Injury With Physiotherapy Services During Inpatient Rehabilitation

49. Transducin-Like Enhancer of Split 3 (TLE3) Expression Is Associated with Taxane Sensitivity in Nonserous Ovarian Carcinoma in a Three-Cohort Study

50. Reversion of BRCA1/2 Germline Mutations Detected in Circulating Tumor DNA From Patients With High-Grade Serous Ovarian Cancer

Catalog

Books, media, physical & digital resources